Categories
Stocks News Business News Global News Market News Earnings News IPO News
Quick Links
Ongoing IPO's Upcoming IPO's Closed IPO's Research Call's

premenstrual dysphoric disorder

  1. H

    Alembic Pharmaceuticals Receives USFDA Approval for Paroxetine Tablet

    Alembic Pharmaceuticals Secures USFDA Approval for Generic Paroxetine Extended-Release Tablets Approval Strengthens Alembic’s US Generics Portfolio New Delhi, March 30: Alembic Pharmaceuticals Ltd on Monday announced that it has received final approval from the United States Food and Drug...
    • Himanshu
    • Thread
    • alembic pharmaceuticals extended-release tablets generic drugs major depressive disorder mental health panic disorder paroxetine premenstrual dysphoric disorder social anxiety disorder supplemental abbreviated new drug application (sanda) usfda
    • Replies: 0
    • Forum: Business
Back
Top